Barclays Raises Hims & Hers Target After Novo Deal Clears
Barclays boosts its target on Hims & Hers Health as Novo Nordisk deal removes a key legal overhang, while Progyny see...
Find out which no annual fee cards provide the highest cash back rewards. Choose wisely to maximize your earnings!
26,626 articlesBarclays boosts its target on Hims & Hers Health as Novo Nordisk deal removes a key legal overhang, while Progyny see...
Roadrunner, the AI-powered CPQ startup, today disclosed a $27 million funding round led by Kleiner Perkins and FOUNDE...
Anthropic stunned markets with a Series H that values the private AI firm near $1 trillion, signaling a new era for p...
When a seasoned manager shifts more weight toward mid-cap stocks, the move often signals conviction about the sector'...
A sharp-eyed coin shop owner stopped a potentially devastating fraud, turning a planned gold payout into a fictional ...
This week brought a sharp pullback in precious metals equities. We break down what drove the move, how it affects New...
Urban air mobility could redefine commuting, but investing in Joby Aviation requires weighing regulation, costs, and ...
A stock split made shares cheaper, but the real driver of Amazon’s rally is its expanding AI and cloud empire. Here’s...
An 8% jump can feel exciting, but a smart investor asks: what’s next? This guide breaks down how to assess a sudden m...
What if a growth‑first approach could deliver compelling risk‑adjusted returns without relying on a stock’s size? Thi...
Peloton’s leadership change nudges the stock market today into focus. This article breaks down what Sid Thacker’s CFO...
Starting with $1,000? This hands-on guide shows you how to build a solid starter portfolio. Learn a practical mix of ...